Lacticaseibacillus paracasei GM-080 Ameliorates Allergic Airway Inflammation in Children with Allergic Rhinitis: From an Animal Model to a Double-Blind, Randomized, Placebo-Controlled Trial

被引:17
|
作者
Lin, En-Kwang [1 ,2 ]
Chang, Wen-Wei [3 ,4 ]
Jhong, Jhih-Hua [5 ]
Tsai, Wan-Hua [6 ]
Chou, Chia-Hsuan [6 ]
Wang, I-Jen [7 ,8 ,9 ,10 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112304, Taiwan
[2] Taipei Med Univ, Wanfang Hosp, Dept Surg, Div Colorectal Surg, Taipei 110301, Taiwan
[3] Chung Shan Med Univ, Sch Biomed Sci, Taichung, Taiwan
[4] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[5] Hsinchu MacKay Mem Hosp, Dept Med Res, Hsinchu, Taiwan
[6] GenMont Biotech Inc, Res & Dev Dept, Tainan, Taiwan
[7] Taipei Hosp, Dept Pediat, Minist Hlth & Welf, New Taipei 242033, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei 112304, Taiwan
[9] China Med Univ, Coll Publ Hlth, Taichung, Taiwan
[10] Taipei Hosp, Dept Pediat, Minist Hlth & Welf, 127 Su-Yuan Rd, Miaoli, Taiwan
关键词
allergic airway inflammation; animal model; allergic rhinitis; clinical trial; probiotics; MUCUS PRODUCTION; PROBIOTICS; GENOME; RESPONSES; HISTORY; MICE; DNA;
D O I
10.3390/cells12050768
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Probiotics may facilitate the clinical management of allergic diseases. However, their effects on allergic rhinitis (AR) remain unclear. We examined the efficacy and safety of Lacticaseibacillus paracasei GM-080 in a mouse model of airway hyper-responsiveness (AHR) and in children with perennial AR (PAR) by using a double-blind, prospective, randomized, placebo-controlled design. Methods: The production of interferon (IFN)-gamma and interleukin (IL)-12 was measured by using an enzyme-linked immunosorbent assay. GM-080 safety was evaluated via the whole-genome sequencing (WGS) of virulence genes. An ovalbumin (OVA)-induced AHR mouse model was constructed, and lung inflammation was evaluated by measuring the infiltrating leukocyte content of bronchoalveolar lavage fluid. A clinical trial was conducted with 122 children with PAR who were randomized to receive different doses of GM-080 or the placebo for 3 months, and their AHR symptom severity scores, total nasal symptom scores (TNSSs), and Investigator Global Assessment Scale scores were examined. Results: Among the tested L. paracasei strains, GM-080 induced the highest IFN-gamma and IL-12 levels in mouse splenocytes. WGS analysis revealed the absence of virulence factors or antibiotic-resistance genes in GM-080. The oral administration of GM-080 at 1 x 10(7) colony forming units (CFU)/mouse/day for 8 weeks alleviated OVA-induced AHR and reduced airway inflammation in mice. In children with PAR, the oral consumption of GM-080 at 2 x 10(9) CFU/day for 3 months ameliorated sneezing and improved Investigator Global Assessment Scale scores significantly. GM-080 consumption led to a nonsignificant decrease in TNSS and also nonsignificantly reduced IgE but increased INF-gamma levels. Conclusion: GM-080 may be used as a nutrient supplement to alleviate airway allergic inflammation.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Nasal cellulose powder in children with allergic rhinitis, a randomized, double-blind, placebo-controlled trial
    Klangkalya, N.
    Manuyakorn, W.
    Kamchaisatian, W.
    Benjaponpitak, S.
    ALLERGY, 2017, 72 : 428 - 428
  • [2] Effect of Nebulized Beclomethasone on Airway Inflammation and Clinical Status of Children with Allergic Asthma and Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study
    Profita, Mirella
    Riccobono, Loredana
    Bonanno, Anna
    Chanez, Pascal
    Gagliardo, Rosalia
    Montalbano, Angela Marina
    Albano, Giusy Daniela
    Liotta, Giuseppe
    Gjomarkaj, Mark
    La Grutta, Stefania
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2013, 161 (01) : 53 - 64
  • [3] A Double-Blind, Randomized, Placebo-Controlled Trial of Acupuncture for the Treatment of Childhood Persistent Allergic Rhinitis
    Raymund Pothmann
    Daniel K. Ng
    Pok-yu Chow
    Shun-pei Ming
    Siu-hung Hong
    Sunny Lau
    Debbie Tse
    Handong Li
    Jackson C. Ho
    Wilson K. Kwong
    Mui-fong Wong
    Wilfred H. Wong
    Yu-ming Fu
    Ka-li Kwok
    Deutsche Zeitschrift für Akupunktur, 2008, 51 (1) : 54 - 55
  • [4] A double-blind, randomized, placebo-controlled trial of acupuncture for the treatment of childhood persistent allergic rhinitis
    Ng, DK
    Chow, PY
    Ming, SP
    Hong, SH
    Lau, S
    Tse, D
    Kwong, WK
    Wong, MF
    Wong, WH
    Fu, YM
    Kwok, KL
    Li, HD
    Ho, JC
    PEDIATRICS, 2004, 114 (05) : 1242 - 1247
  • [5] Double-Blind Placebo-Controlled Trial of Bepotastine Salicylate in Patients With Allergic Rhinitis
    Mo, Ji-Hun
    Jeong, Jin Hyeok
    Kim, Tae Hoon
    Kim, Seon-Tae
    Kim, Soo Whan
    Lee, Kun Hee
    Hong, Seung-No
    Kim, Hyo Yeol
    Kim, Dae Woo
    Kim, Dong-Young
    Kim, Chang-Hoon
    Cho, Seok Hyun
    Rhee, Chae-Seo
    LARYNGOSCOPE, 2021, 131 (03): : E702 - E709
  • [6] Cardiometabolic benefits of Lacticaseibacillus paracasei 8700:2: A randomized double-blind placebo-controlled trial
    Yang, Jialu
    Huang, Jingyi
    Huang, Zhihao
    Xu, Yingxi
    Li, Wenkang
    Zhu, Shanshan
    Zhao, Yawen
    Ye, Bingqi
    Liu, Ludi
    Zhu, Jiangyuan
    Xia, Min
    Liu, Yan
    CLINICAL NUTRITION, 2023, 42 (09) : 1637 - 1646
  • [7] Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring
    Philip, G
    Malmstrom, K
    Hampel, FC
    Weinstein, SF
    LaForce, CF
    Ratner, PH
    Malice, MP
    Reiss, TF
    CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (07): : 1020 - 1028
  • [8] Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
    Bager, Peter
    Arnved, John
    Ronborg, Steen
    Wohlfahrt, Jan
    Poulsen, Lars K.
    Westergaard, Tine
    Petersen, Henning Willads
    Kristensen, Bjarne
    Thamsborg, Stig
    Roepstorff, Allan
    Kapel, Christian
    Melbye, Mads
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (01) : 123 - 130
  • [9] Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
    Zhang, Junyan
    Yang, Xiaobin
    Chen, Guangui
    Hu, Jintao
    He, Ying
    Ma, Jinxiang
    Ma, Zhaoen
    Chen, Huifang
    Huang, Yuyi
    Wu, Qiurong
    Liu, Yongping
    Yu, Lu
    Zhang, Hong
    Lai, He
    Zhang, Jianguo
    Zhai, Jinming
    Huang, Minqi
    Zou, Zehong
    Tao, Ailin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 346 - 354.e1
  • [10] Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Potter, Paul
    Maspero, Jorge F.
    Vermeulen, Jan
    Barkai, Laszlo
    Nemeth, Ildiko
    Baillieau, Rene A.
    Garde, Jesus M.
    Giralt, Josep
    Domenech, Alejandro
    Izquierdo, Inaki
    Nieto, Antonio
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (02) : 144 - 150